Bile???Acid???Sequestrants???and???the???Treatment of Type??2??Diabetes??Mellitus
- 1 January 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 67 (10), 1383-1392
- https://doi.org/10.2165/00003495-200767100-00001
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Prevention and Treatment of Obesity, Insulin Resistance, and Diabetes by Bile Acid–Binding ResinDiabetes, 2007
- Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?FEBS Letters, 2006
- Transient impairment of the adaptive response to fasting in FXR‐deficient miceFEBS Letters, 2005
- Oral Antidiabetic AgentsDrugs, 2005
- Chronic Effect of Oral Cholestyramine, a Bile Salt Sequestrant, and Exogenous Cholecystokinin on Insulin Release in RatsPancreas, 1992
- Feeding Rats Diets Containing Cheno- or Ursodeoxycholic Acid or Cholestyramine Modifies Intestinal Uptake of Glucose and LipidsDigestion, 1987
- Effect of streptozotocin-induced diabetes in neonatal rat on bile acid pool changes in adult life: Selective sensitivity in femalesBiochemical Medicine, 1984
- Effect of maternal diabetes on fetal bile acid metabolism in the ratBiochemical Medicine, 1981
- Bile acid pool changes and regulation of cholate synthesis in experimental diabetesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Effects of Diabetes Mellitus on Cholesterol Metabolism in ManNew England Journal of Medicine, 1977